About Amrapali Capital and Finance Services Ltd
Amrapali Capital & Finance Services is engaged in the business of broking activities, shares trading, commodity trading and financing activities. The company is recognized broker of BSE & NSE and main activity of the company is broking activities.
Founded
1994
CEO
Alkesh Patel
Employees
28
HQ
Silvassa, Dadra & Nagar Haveli
Finished Products
1Bonds-Sales
₹99.64Cr2Interest
₹7.29Cr3Investment Operations
₹7.25Cr4SURPLUS/(LOSS) FROM SHARE TRAD
₹3.45Cr5Commission
₹0.79Cr6Brokerage
₹0.57Cr7Fee Income
₹0.12Cr1–7 of 9
Raw Materials
1Bond Purchase
₹97.80Cr2Purchase of Stock in Trade
₹70.11CrAbout Amrapali Capital and Finance Services Ltd
Amrapali Capital & Finance Services is engaged in the business of broking activities, shares trading, commodity trading and financing activities. The company is recognized broker of BSE & NSE and main activity of the company is broking activities.
Founded:1994
CEO:Alkesh Patel
Employees:28
HQ:Silvassa, Dadra & Nagar Haveli
Finished Products
1Bonds-Sales
₹99.64Cr2Interest
₹7.29Cr3Investment Operations
₹7.25Cr4SURPLUS/(LOSS) FROM SHARE TRAD
₹3.45Cr5Commission
₹0.79Cr6Brokerage
₹0.57Cr7Fee Income
₹0.12Cr1–7 of 9
Raw Materials
1Bond Purchase
₹97.80Cr2Purchase of Stock in Trade
₹70.11CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹82
52W Low
₹21
Volume3.60K
Avg VolumeN/A
BetaN/A
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
11.54x
Valuation
P/B Ratio
0.63x
Valuation
EPS
₹4.97
Valuation
Dividend Yield
0.00%
Valuation
ROE
5.48%
Profitability
ROCE
8.50%
Profitability
Revenue by Segment
Contribution & growth by business line
Trading In Shares & SecuritiesRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.35x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
47.4%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.